Login

This is how a successful IT career began in Salzburg | Peter Belly, Managing Director, B+S Banksysteme AGDTD2X:GER 00:10:00

Share On Facebook Share On Twitter

Peter Belly is the managing director of B+S Banksysteme

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
René C. Goehrum | Chairman, President & Chief Executive Officer, Biosyent Inc
00:10:00
"Building Trust: How SBL Contractors Ltd. and ICM Asset Management Forge Strong Partnerships in Alternative Investments"
00:10:00
Interview with Tom Dean, CEO and Founder of Avista Capital
00:10:00
Navigating Market Uncertainty Amid Global Events
00:00:00
ReNeuron Group's phase IIb stroke trial kicks off with first patient treated - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Robert Itschner, CEO of BKW, will be featured at THE SPIRIT OF BERN event on May 7 at the Kursaal Bern.
00:10:00
Gold Play Exploration: Advancing Silver Asset in Mexico's Rosario Mining District
00:10:00
The Rise of Metro Brands: Nissan Joseph Explores Footwear Expansion and Market Development | Nissan Joseph, CEO, Metro Brands Ltd.
00:10:00
ISG Presentation at NobleCon17: Driving Global Technology Transformation | Michael P. Connors - Chairman & CEO of Information Services Group, Inc.
00:10:00
Best Practices for Writing and Reviewing State Regulatory Communications
00:10:00
KNect365 Life Sciences about the company she co-founded as the latest spinout of Cold Spring Harbor Laboratory|Maria Luisa Pineda , CEO OF ENVISAGENICS, INC
00:10:00
Investing in Latina those who with high growth potential|Gary Acosta,Co-Founder,LATTITUDE Ventures

© 2017 - Neuhu+